In another study, a primary tumor from a bitransgenic KrasG12C mouse observed the phosphorylation of RAS-downstream effector factors: ERK, p38, p90 ribosomal S6 kinase (RSK), and MAP kinase-active protein kinase 2 (MAPKAPK-2) [43]. The gene discussed is MAPKAPK2; the disease is neoplasm.